arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Inogen Inc

INGN
$6.06 ▼ -0.41 (-6.34%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
15 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Inogen Inc faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $161.2M
Dividend Yield
Revenue Growth 3.9%
Op. Margin -8.7%
ROIC -15.3%
FCF / Share $-0.52
Trailing P/E
Price / Book 0.9x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$348.67M
↑ +3.9%
Net Income Profit after all expenses
$-22.75M
↑ +36.6%
Operating Margin Operating profit as % of sales
-8.7%
↑ +31.6% 16th
FCF / Share Free cash flow per share
$-0.52
↓ -578.3%
Long-Term Debt Long-term obligations
$315.00K
↓ -48.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
18
Returns
33
Cash Quality
44

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 57 quarters